Therapeutic potential of CBD in Autism Spectrum Disorder (2024)
- Authors:
- USP affiliated authors: HALLAK, JAIME EDUARDO CECILIO - FMRP ; GUIMARAES, ELAINE APARECIDA DEL BEL BELLUZ - FORP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; PEDRAZZI, JOÃO FRANCISCO CORDEIRO - FMRP ; CAMINA, LUCAS HASSIB - FMRP
- Unidades: FMRP; FORP
- DOI: 10.1016/bs.irn.2024.05.002
- Subjects: TRANSTORNO DO ESPECTRO AUTISTA; CANABINOIDES; ENSAIO CLÍNICO; FARMACOLOGIA MÉDICA
- Language: Inglês
- Imprenta:
- Publisher: 10.1016/bs.irn.2024.05.002
- Publisher place: London
- Date published: 2024
- Source:
- Título: International review of neurobiology: cannabidiol in neurology and psychiatry
- Volume/Número/Paginação/Ano: 334 p.
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
PEDRAZZI, João Francisco Cordeiro et al. Therapeutic potential of CBD in Autism Spectrum Disorder. International review of neurobiology: cannabidiol in neurology and psychiatry. Tradução . London: 10.1016/bs.irn.2024.05.002, 2024. p. 334 . Disponível em: https://doi.org/10.1016/bs.irn.2024.05.002. Acesso em: 27 dez. 2025. -
APA
Pedrazzi, J. F. C., Camina, L. H., Ferreira, F. R., Hallak, J. E. C., Del Bel, E. A., & Crippa, J. A. de S. (2024). Therapeutic potential of CBD in Autism Spectrum Disorder. In International review of neurobiology: cannabidiol in neurology and psychiatry (p. 334 ). London: 10.1016/bs.irn.2024.05.002. doi:10.1016/bs.irn.2024.05.002 -
NLM
Pedrazzi JFC, Camina LH, Ferreira FR, Hallak JEC, Del Bel EA, Crippa JA de S. Therapeutic potential of CBD in Autism Spectrum Disorder [Internet]. In: International review of neurobiology: cannabidiol in neurology and psychiatry. London: 10.1016/bs.irn.2024.05.002; 2024. p. 334 .[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/bs.irn.2024.05.002 -
Vancouver
Pedrazzi JFC, Camina LH, Ferreira FR, Hallak JEC, Del Bel EA, Crippa JA de S. Therapeutic potential of CBD in Autism Spectrum Disorder [Internet]. In: International review of neurobiology: cannabidiol in neurology and psychiatry. London: 10.1016/bs.irn.2024.05.002; 2024. p. 334 .[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/bs.irn.2024.05.002 - The therapeutic potential of harmine and ayahuasca in depression: evidence from exploratory animal and human studies
- Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine
- Postural balance in patients with social anxiety disorder
- Short-term treatment of Catatonia with amantadine in schizophrenia and schizoaffective disorder. [Carta]
- New treatment options for panic disorder: clinical trials from 2000 to 2010
- Public speaking in social phobia: a pilot study of self-ratings and observers' ratings of social skills
- Arterial spin labeling in patients with schizophrenia: a systematic review
- Randomized, open naturalistic, acute treatment of panic Disorder with clonazepam or paroxetine [carta]
- Antipsicóticos e alterações metabólicas
- Default mode network changes induced by Ayahuasca
Informações sobre o DOI: 10.1016/bs.irn.2024.05.002 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003244814.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
